Abiopharma

🔍 Carmichael John Patrick (Executive)

Company: KIMBERLY CLARK CORP (KMB)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 12,286 shares of Restricted Share Units 5/1/2026 (w/dividends reinvested) (Derivative)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 12,286.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2, F2

Footnotes:

• F1: Restricted share units payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Equity Participation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock.
• F2: The restricted share units vest 30 percent on each of the first and second anniversaries of the grant date and the remaining 40 percent on the third anniversary of the grant date.